BeStock  
Stocks › Biotechnology › RIGL

Rigel Pharmaceuticals RIGL

US equityMarket cap rank #3339Biotechnology
$40.09 −$1.10 (-2.67%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $40.00 -0.22%
Open$40.65
Prev close$41.19
Day range$39.62 – $41.66
Volume352.2K
Market cap$754.89M
P/E (TTM)2.5
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings2.8x
CheapRich

Above its usual level · 70th percentile, 5-year average 1.1x

#124 of 2991 stocks by PE (1 = cheapest)

Price / book1.9x
CheapRich

Above its usual level · 61st percentile, 5-year average 0.4x

#2949 of 5329 stocks by PB (1 = cheapest)

Price / sales2.9x
CheapRich

Near the top of its 5-year range · 81st percentile, 5-year average 2.2x

#3103 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-83x-17x48x114xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$50.67
Price vs. fair value-20.9%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.88 – 0.43 61% (pricier than usual) #2949 of 5329 (1 = cheapest)
PE 2.77 12.02 1.07 70% (pricier than usual) #124 of 2991 (1 = cheapest)
PS 2.90 2.39 2.23 81% (pricier than usual) #3103 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on RIGL.

Sign in to join the discussion.

Scroll to Top